dexcom

Dexcom Launches the First Generative AI Platform in Glucose Biosensing

Press Release – December 17, 2024 – SAN DIEGO – DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today it has launched a proprietary Generative AI (GenAI) platform, making Dexcom the first CGM manufacturer to integrate GenAI into glucose biosensing technology.1 The new Dexcom GenAI platform will analyze individual health data patterns to reveal a direct association between lifestyle choices and glucose levels while providing … Continue reading Dexcom Launches the First Generative AI Platform in Glucose Biosensing

Samsara Vision

Samsara Vision Promotes Jason Herod to Chief Commercial Officer

FAR HILLS, N.J. – Samsara Vision today announced that Jason Herod, Vice President Commercial, International Markets, is promoted to Chief Commercial Officer, effective August 15, 2024. Samsara Vision is a privately held specialty medical device company focused on intraocular ophthalmic devices that are intended to significantly improve vision and quality of life for individuals with untreatable retinal disorders. Jason Herod joined Samsara Vision in August 2021 … Continue reading Samsara Vision Promotes Jason Herod to Chief Commercial Officer

Butterfly Network

Butterfly Network Appoints Steve Cashman as Chief Business Officer

Seasoned Healthcare Leader to Drive Growth Strategy and Amplify Continued Commercial Momentum BURLINGTON, Mass. & NEW YORK – Butterfly Network, Inc. (NYSE: BFLY), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced the appointment of Steve Cashman as Chief Business Officer (CBO), effective today. Cashman joins Butterfly at an exciting juncture, following the Company’s successful launch of its third-generation Butterfly … Continue reading Butterfly Network Appoints Steve Cashman as Chief Business Officer

Paragonix Technologies

Paragonix Technologies Signs Definitive Agreement to be Acquired by Getinge

Paragonix and Getinge aim to expand the reach of transformative organ preservation technologies globally and launch new innovations in transplantation from their combined capabilities. WALTHAM, Mass. – Paragonix Technologies, a leading organ transplant company, announced today that it has entered into a definitive agreement to be acquired by Getinge. This strategic acquisition will enhance Getinge’s global healthcare portfolio to also address needs in solid organ … Continue reading Paragonix Technologies Signs Definitive Agreement to be Acquired by Getinge

Elucid

Elucid Names Kelly Huang as CEO

Experienced commercial leader takes helm to expand cardiovascular diagnostic company globally and commercialize company’s flagship plaque analysis software BOSTON – Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software based on ground truth histology to support treatment of cardiovascular disease, has named Kelly Huang, PhD, as president and chief executive officer (CEO). The appointment comes as Elucid continues to prepare for … Continue reading Elucid Names Kelly Huang as CEO